Moderna wins patent dispute towards Biontech and Pfizer

The European Patent Workplace has determined to take care of the validity of Moderna’s patent EP949, Moderna introduced by e-mail on Friday. It’s assumed that the rivals will attraction towards this, it was additionally mentioned. Pfizer and Biontech initially didn’t remark.

That is one among a number of patent disputes introduced by biotech firms. The EU Patent Workplace revoked a Moderna patent in November 2023. And within the USA, Moderna filed a patent lawsuit towards Pfizer and Biontech in 2022 over allegations of copying Moderna’s Covid-19 vaccine know-how. Nonetheless, the patent lawsuit was interrupted in April. The US Patent Workplace ought to look at the validity of two of the three Moderna patents in query.

ePaper

Learn the ePaper now!

Learn the each day ePaper version of the OÖNachrichten – flick through it digitally now!

to the e-paper

data By clicking on the icon you’ll be able to add the key phrase to your matters.

data
By clicking on the icon you open your “my matters” web page. They’ve of 15 key phrases saved and must take away key phrases.

data By clicking on the icon you’ll be able to take away the key phrase out of your matters.

Add the subject to your matters.